Gallocatechin-(4alpha->8)-catechin-(4alpha->8)-catechin



Compound IDCDAMM00367
Common nameGallocatechin-(4alpha->8)-catechin-(4alpha->8)-catechin
IUPAC name2-(3,4-dihydroxyphenyl)-4-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-8-[3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol
Molecular formulaC45H38O19

Experimental data

Retention time30.022
Adduct[M+H]+
Actual mz883.214
Theoretical mz883.208
Error6.34
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.24

Identifiers and class information

Inchi keyRGJAJCOCOZWPNI-UHFFFAOYNA-N
SmilesOC=1C=C(O)C2=C(OC(C3=CC(O)=C(O)C(O)=C3)C(O)C2C4=C(O)C=C(O)C5=C4OC(C6=CC=C(O)C(O)=C6)C(O)C5C=7C(O)=CC(O)=C8C7OC(C9=CC=C(O)C(O)=C9)C(O)C8)C1
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)14
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)16
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)882.784
Computed dipole moment(dipole)5.953
Total solvent accessible surface area (SASA)1123.67
Hydrophobic component of SASA (FOSA)88.026
Hydrophilic component of SASA (FISA)631.738
Pie component of the SASA (PISA)403.906
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2251.2
Number of hydrogen bond donors (donorHB)16
Number of hydrogen bond acceptors (accptHB)17.1
Free energy of solvation of dipole (dip^2/V)0.0157402
Index of cohesive interaction in solids (ACxDN^.5/SA)0.060872
Globularity descriptor (glob)0.739268
Predicted polarizability in cubic angstroms (QPpolrz)77.523
Predicted hexadecane/gas partition coefficient (QPlogPC16)30.309
Predicted octanol/gas partition coefficient (QPlogPoct)61.375
Predicted water/gas partition coefficient (QPlogPw)46.216
Predicted octanol/water partition coefficient (QPlogPo/w)-0.343
Predicted aqueous solubility (QPlogS)-5.612
Conformation-independent predicted aqueous solubility (CIQPlogS)-10.786
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.677
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.01
Predicted brain/blood partition coefficient (QPlogBB)-8.107
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.002
Predicted skin permeability, log Kp (QPlogKp)-10.203
PM3 calculated ionization potential (IP(ev))8.744
PM3 calculated electron affinity (EA(eV))0.075
Number of likely metabolic reactions (#metab)22
Prediction of binding to human serum albumin (QPlogKhsa)-0.418
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)351.075
Number of nitrogen and oxygen atoms (#NandO)19
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P22748CA4Carbonic anhydrase IVT53378SEA
P08253MMP2Matrix metalloproteinase 2T68251SwissTargetPrediction
P14780MMP9Matrix metalloproteinase 9T54156SwissTargetPrediction
P20151KLK2Kallikrein 2T01908SEA
P15692VEGFAVascular endothelial growth factor AT20761SwissTargetPrediction and SEA
P49763PGFPlacenta growth factorT70792SwissTargetPrediction and SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T68251DI0238Lung cancer[ICD-11: 2C25]P08253MMP2
T54156DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P14780MMP9
T54156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P14780MMP9
T54156DI0395Stomach cancer[ICD-11: 2B72]P14780MMP9
T54156DI0419Ulcerative colitis[ICD-11: DD71]P14780MMP9
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1

Copyright © 2025